Novo Nordisk's Discount, Pernod Ricard Dips, Next Jitters

On this episode of Stock Movers:
- European pharmaceutical stocks may be active after the US government said Tuesday that it negotiated a 71% discount of the list price of Novo Nordisk's drugs Ozempic and Wegovy for patients in Medicare. 
- Pernod Ricard is dipping after JPMorgan is taking a generally cautious stance on European consumer staples heading into 2026, with higher unemployment and low consumer confidence expected to see delivery again weighted to second half of the year, driven by fiscal packages and easier comparatives.
- Next is one of the companies on the frontline in today's UK budget as companies watch for a possible patchwork of levies.

See omnystudio.com/listener for privacy information.